Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × neratinib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasm Metastasis 4 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasms 1 Meningioma 1 Malignant Female Reproductive System Neoplasm 1 Inflammatory Breast Neoplasms 1 Hemangiosarcoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 Endometrial Neoplasms 1

Interventions

ruxolitinib 8 fludarabine 4 Tacrolimus 4 Cyclophosphamide 4 Whole-Body Irradiation 3 Stem Cell Transplantation 3 Specimen Handling 3 venetoclax 2 fludarabine phosphate 2 Mycophenolic Acid 2 Melphalan 2 Decitabine 2 Busulfan 2 Biopsy 2 Azacitidine 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 veliparib 1 selinexor 1 reparixin 1 piperine 1 pevonedistat 1 navitoclax 1 merphos 1 iadademstat 1 fedratinib 1 elotuzumab 1 demethoxycurcumin 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 axatilimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡